Robert Bloom, MD
Pediatric Ophthalmology and Strabismus Specialist · Dayton, OHNPI 1578512893
Payments from drug & device makers
Across 234 payments — averaging $53.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Amgen$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- Bausch & Lomb Americas Inc.$960
- AbbVie$875
- Mallinckrodt Hospital Products Inc.$484
- plus $5K from 28 others
What the payments were for
- Food & beverage$12,22197%
- Education$1982%
- Entertainment$1731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 42 | $2,525 |
| Amgen(2 entities) | 60 | $1,977 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $1,009 |
| Bausch & Lomb Americas Inc. | 14 | $960 |
| AbbVie(2 entities) | 20 | $875 |
| Mallinckrodt Hospital Products Inc. | 8 | $484 |
| Biotissue Holdings Inc. | 14 | $466 |
| Sight Sciences, Inc. | 3 | $374 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $366 |
| Glaukos Corporation | 3 | $326 |
| Sandoz | 5 | $314 |
| Regeneron Healthcare Solutions, Inc. | 4 | $302 |
| ANI Pharmaceuticals, Inc. | 4 | $286 |
| Mallinckrodt Enterprises LLC | 2 | $223 |
| Aerie Pharmaceuticals, Inc. | 4 | $216 |
| Optos, Inc. | 2 | $173 |
| Microsurgical Technology, Inc. | 1 | $152 |
| Rxsight Inc | 2 | $152 |
| Astellas Pharma US Inc | 2 | $143 |
| NEW World Medical,inc. | 2 | $140 |
| Oyster Point Pharma, Inc. | 2 | $138 |
| Harrow Eye, LLC | 2 | $138 |
| Ivantis, Inc | 1 | $125 |
| Rayner Intraocular Lenses Limited | 1 | $124 |
| Apellis Pharmaceuticals, Inc. | 1 | $123 |
| Shire North American Group Inc | 1 | $115 |
| Tarsus Pharmaceuticals, Inc. | 5 | $108 |
| Johnson & Johnson Vision Care, Inc. | 2 | $51 |
| Carl Zeiss Meditec, Inc. | 1 | $50 |
| Dompe US, Inc. | 2 | $48 |
| Eyevance Pharmaceuticals LLC | 2 | $33 |
| Genentech USA, Inc. | 1 | $26 |
| Alimera Sciences, Inc. | 1 | $25 |
| Thea Pharma Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$767
- Clareon$516
- Centurion$464
- INFUSE$436
- Hydrus Microstent$376
- PANORAMIC OPHTHALMOSCOPE$312
- OCT OPHTHALMOSCOPE$312
- OMNI(R) SURGICAL SYSTEM (US)$277
- BTOD$250
- PURIFIED CORTROPHIN GEL$246
- Unity$241
- BIOTRUE ONE DAY$219
- iStent Trabecular Micro-Bypass System Model iS3$197
- ENVISTA ASPIRE TORIC IOL$160
- STELLARIS$160
- NFC-700$156
- ACTHAR$148
- Cimerli$145
- RXSIGHT CONTACT LENS$134
- RXSIGHT INJECTOR CARTRIDGE$134
How this compares
Too few pediatric ophthalmology and strabismus specialist providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 55 | $25,677 |
| LumiganBimatoprost | 26 | $6,891 |
| Prednisolone Acetate | 217 | $5,067 |
| MoxifloxacinMoxifloxacin Hcl | 110 | $4,128 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 179 | $2,755 |
| Latanoprost | 343 | $2,323 |
| Ketorolac Tromethamine | 109 | $1,625 |
| Brimonidine Tartrate | 56 | $1,480 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 96 | $797 |
| Acetazolamide ErAcetazolamide | 19 | $530 |
| ValacyclovirValacyclovir Hcl | 25 | $488 |
| Diclofenac Sodium | 20 | $335 |
| Timolol Maleate | 16 | $302 |
| Ciprofloxacin Hcl | 14 | $157 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 20 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Aerie Pharmaceuticals, Inc.Rocklatan | $216 | $25,67755 claims |
| AbbVieLumigan | $875 | $6,89126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pediatric ophthalmology and strabismus specialist providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other pediatric ophthalmology and strabismus specialist in Dayton
- Michael BloomDayton$10K
- Luxme HariharanDayton$505
- Marina EisenbergBeachwood$16K
- Syeda Ahmed NaqviBlue Ash$6K
- Veeral ShahCincinnati$6K
- Allison BabiuchCleveland$149
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.